Anti-Human IL6R Recombinant Antibody(Satralizumab)

Name: Anti-Human IL6R Recombinant Antibody(Satralizumab)
Brand: KMD Bioscience
SKU: YR1396

YR1396

科研级 Satralizumab ( 萨特利珠单抗, 沙利珠单抗 ), Anti-IL6R Recombinant Antibody, Research Grade Satralizumab

DATASHEET MSDS

Product Description

Alias	科研级 Satralizumab ( 萨特利珠单抗, 沙利珠单抗 ), Anti-IL6R Recombinant Antibody, Research Grade Satralizumab
Catalog Number	YR1396
Molecular Name	Satralizumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG2 Kappa
Formulation	PBS, pH7.5
Background	Satralizumab, sold under the brand name Enspryng, is a humanized monoclonal antibody medication that is used for the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease. The drug is being developed by Chugai Pharmaceutical, a subsidiary of Roche.
CAS Number	1535963-91-7
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	IL6R[Homo sapiens]

Login